Compare
Johnson & Johnson vs Phibro Animal Health (JNJ vs PAHC)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and Phibro Animal Health (PAHC) -19.9%; so far this year the figures are +33.5% and -11.8%.
Johnson & Johnson is the larger company by market value, about 492.6 times the size of Phibro Animal Health.
On trailing earnings, JNJ trades at 41.9 times and PAHC at 13.1 times.
Revenue grew +7.8% at JNJ and +10.1% at PAHC over the last year.
JNJ yields 1.91%. PAHC yields 1.46%.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | PAHC | |
|---|---|---|
| Price | $276.22 | $32.96 |
| 1-day | +1.43% | -6.89% |
| YTD | +33.47% | -11.78% |
| 1 year | +48.51% | -19.90% |
| 3 years | +85.77% | +194.55% |
| Market cap | $665.0B | $1.4B |
| P/E | 41.9 | 13.1 |
| P/S | 6.69 | 0.88 |
| P/B | 8.16 | 3.23 |
| Revenue growth | +7.80% | +10.10% |
| EPS growth | -36.40% | +50.30% |
| Gross margin % | 67.6 | 33.8 |
| Net margin % | 16.2 | 6.7 |
| ROE % | 19.7 | 24.6 |
| Debt / equity | 0.55 | 1.46 |
| FCF yield % | 3.1 | 1.6 |
| Dividend yield % | 1.91 | 1.46 |
| Beta | -0.09 | 0.92 |
| RSI (14) | 59.4 | 33.0 |
| Technical rating |